Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Nexalin Technology, Inc. (NXL) just unveiled an update.
Michael Nketiah will step down as Nexalin Technology Inc.’s Senior Vice President of Clinical, Quality, & Regulatory Affairs on August 16, 2024, to pursue a new professional opportunity. His departure is amicable, with no disagreements with the company reported. Nketiah will continue his duties until the effective date of his resignation.
For an in-depth examination of NXL stock, go to TipRanks’ Stock Analysis page.